%0 Journal Article
%T Pulmonary metastasectomy for sarcoma¡ªsurvival and prognostic  analysis
%A Horia Sirbu
%A Iurii Mykoliuk
%A Mostafa Higaze
%A Waldemar Schreiner
%A Wojciech Dudek
%J SCIE-indexed Journal
%D 2019
%R 10.21037/jtd.2019.08.10
%X Despite a lack of evidence, surgery has become the mainstay of treatment in patients with pulmonary metastatic sarcoma over the last decades. Five-year survival rates ranging from 15% to >50% following pulmonary metastasectomy (PM) in patients with resectable disease have been reported (1,2). Histology and grade of the primary tumour, number of metastatic nodules, disease-free interval (DFI) and resectability have been identified as prognostic survival factors in sarcoma (1-3). Recently, the association of systemic inflammation with poor prognosis in soft tissue sarcoma (STS) patients has been reported (4). Also, the nutritional patient status has been identified as a predictor of postoperative outcome and survival in various malignancies (5,6)
%U http://jtd.amegroups.com/article/view/31029/html